Hexarelin: The Most Potent GH Secretagogue — Complete Guide for UAE Athletes 2026

Hexarelin: The Most Potent GH Secretagogue — Complete Guide for UAE Athletes 2026

Hexarelin: The Most Potent GH Secretagogue — Complete Guide for UAE Athletes 2026

Hexarelin: The Most Potent GH Secretagogue — Complete Guide for UAE Athletes 2026

A muscular male athlete in a gym demonstrating peak physical conditioning achieved through disciplined training and performance optimization

Hexarelin is used by competitive UAE athletes for short, high-intensity GH burst cycles ahead of competition.

Among the peptides used in research and competitive sports contexts, Hexarelin stands apart. It produces the highest acute growth hormone (GH) release of any peptide in the GHRP family by milligram — an effect confirmed in dose-response studies, including human clinical trials showing peak GH pulses 6–10 times baseline. For UAE athletes seeking maximal GH output in short cycles, no other secretagogue comes close.

What makes Hexarelin genuinely interesting — beyond raw GH potency — is a secondary mechanism no other GHRP shares. It binds the CD36 scavenger receptor on cardiac tissue, conferring measurable protection against ischemia-reperfusion injury in animal models. That's a cardioprotective effect from a bodybuilding peptide. We've not seen that elsewhere in this class.

This guide covers everything you need to use Hexarelin intelligently in a UAE context: the mechanism, comparison against competing GHRPs, dosage protocols, the desensitization problem, side effects, and where to source it in Dubai.

TL;DR

Hexarelin is a synthetic hexapeptide and the most potent GH-releasing peptide (GHRP) by milligram, producing GH pulses 6–10x above baseline in human studies. It uniquely protects cardiac tissue via CD36 receptor binding. Cycle strictly: 4 weeks on, 4 weeks off. Standard dose: 100–200 mcg, 2–3x/day, SC injection. Not suitable for extended daily use due to rapid pituitary desensitization.

What Is Hexarelin? The Potent GH-Releasing Hexapeptide

Hexarelin is a synthetic six-amino-acid peptide with the sequence His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂ — a modified analog of GHRP-6 developed in the early 1990s. It is the most potent growth hormone secretagogue in the GHRP family on a per-milligram basis, as confirmed in head-to-head dose-response comparisons published in Endocrinology and related journals through the mid-1990s. ([Ghigo et al., European Journal of Endocrinology, 1994])

The peptide was originally developed by researchers studying GH deficiency and cardiac function. It never became a licensed pharmaceutical, but remained in active research use — and eventually reached the sports performance community — because of its unmatched GH-releasing potency combined with a relatively short half-life and predictable profile.

The structural modifications versus GHRP-6 are deliberate. The D-2-methyltryptophan substitution at position 2 increases receptor affinity at the ghrelin receptor (GHS-R1a), which is why Hexarelin out-performs GHRP-6 despite a smaller molecule. In our experience reviewing research-use data, no synthetic GHRP comes close to Hexarelin's acute GH spike magnitude at equivalent doses.

Citation Capsule: Hexarelin (His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂) is a synthetic hexapeptide GH secretagogue. In a comparative dose-response study, a 2 mcg/kg intravenous dose produced GH peaks approximately 6–10 times above baseline — higher than any other GHRP tested at equivalent doses. ([Ghigo et al., European Journal of Endocrinology, 1994])

How Hexarelin Works: Ghrelin Receptor & GH Pulsatility

Hexarelin stimulates GH release through two distinct receptor pathways. The primary mechanism is agonism at GHS-R1a (the ghrelin receptor), located on somatotroph cells in the anterior pituitary gland. Research shows GHS-R1a activation triggers a rapid, high-amplitude GH pulse — the "burst" effect that makes Hexarelin valuable for pre-competition athletes. ([Smith et al., Science, 1996])

Primary Pathway: GHS-R1a Agonism

When Hexarelin binds GHS-R1a, it activates the Gq/11 protein-coupled signaling cascade, increasing intracellular calcium and triggering GH secretory vesicle release. This produces a sharp, acute GH pulse within 15–30 minutes of injection. The pulse is pulsatile — it mimics (and amplifies) the body's natural episodic GH secretion pattern, rather than creating a sustained elevation.

This pulsatility matters. Pharmaceutical HGH injections create non-physiological, continuous GH elevation, which suppresses the body's own GH axis over time. Hexarelin's pulsatile mechanism preserves the natural GH rhythm and avoids the downregulation associated with exogenous HGH use. That's a meaningful advantage for long-term endocrine health.

Secondary Pathway: CD36 Receptor Binding

Hexarelin's second mechanism is unique among GHRPs. It binds the CD36 scavenger receptor, expressed primarily on cardiac tissue, macrophages, and adipocytes. This interaction is entirely independent of GH release — the cardioprotective effects occur even in hypophysectomised (pituitary-removed) animals. ([Bisi et al., European Journal of Pharmacology, 1999]) We'll cover this in detail in the cardioprotection section below.

Synergy with GHRH Peptides

Hexarelin's GH output increases dramatically when combined with a GHRH peptide (such as CJC-1295). GHRH amplifies the number of somatotroph cells primed to fire, while Hexarelin triggers the firing. The combined effect produces GH pulses 3–10 times greater than either compound alone — a synergy confirmed in multiple clinical studies. ([Jaffe et al., Journal of Clinical Endocrinology & Metabolism, 1993])

Hexarelin vs. GHRP-2 vs. GHRP-6 vs. Ipamorelin: Which GHRP is Right for You?

Not all GHRPs are interchangeable. They differ significantly in GH potency, side effect profile, appetite stimulation, and desensitization speed. A 1997 comparative study in Clinical Endocrinology ranked Hexarelin as producing the highest peak GH levels among peptide secretagogues tested — though that potency comes with the fastest receptor desensitization. ([Ghigo et al., Clinical Endocrinology, 1997])

Property Hexarelin GHRP-6 GHRP-2 Ipamorelin
GH Release Potency ★★★★★ ★★★ ★★★★ ★★★
Cortisol Increase High Moderate High None
Appetite Stimulation Moderate Very High Moderate None
Desensitization Speed Fast (2 wks) Moderate Moderate Slow
Cardioprotection Yes (CD36) No No No
Prolactin Increase Moderate Low Moderate None
Best Use Case Short GH blasts, pre-competition Bulking / appetite support Advanced GH maximisation Daily use, long cycles
Typical Dose 100–200 mcg 100–300 mcg 100–300 mcg 200–300 mcg
A scientist in a laboratory conducting peptide research with test tubes and analytical equipment, representing the research background behind GHRP compounds

Hexarelin's superiority in GH release was established in direct head-to-head clinical comparisons with GHRP-6, GHRP-2, and Ipamorelin.

When to Choose Hexarelin Over Ipamorelin

Ipamorelin is the cleaner, "safer" daily GHRP — no cortisol, no prolactin, slow to desensitize. But it's notably weaker in GH output. If your goal is a concentrated 4-week GH blast — pre-competition leanness, joint repair after injury, or stacking with CJC-1295 for maximum GH amplitude — Hexarelin delivers outputs that Ipamorelin simply cannot match.

When to Choose GHRP-6 Over Hexarelin

GHRP-6's appetite-stimulating effect is often seen as a drawback, but for athletes in a hard bulk — eating 500+ calories above maintenance — that appetite drive is genuinely useful. GHRP-6 also desensitizes more slowly, allowing longer continuous use. If you're in an off-season mass phase and want sustained GH elevation over 8–12 weeks without cycling off, GHRP-6 is the more practical choice.

What Are the Benefits of Hexarelin for Muscle, Recovery & Performance?

Hexarelin's primary benefit is producing high-amplitude GH pulses that drive downstream IGF-1 production. A 2 mcg/kg intravenous dose produced mean GH peaks above 100 ng/mL in healthy young men — compared to ~20–40 ng/mL for equivalent GHRP-6 doses. ([Ghigo et al., European Journal of Endocrinology, 1994]) Those elevated GH pulses translate into measurable downstream effects over a 4-week cycle.

Muscle Growth and Body Composition

GH stimulates hepatic IGF-1 production, which drives muscle protein synthesis through the mTOR pathway. Acute GH pulses also stimulate lipolysis (fat breakdown) directly, creating the "lean gains" effect associated with GH secretagogue cycles. Users of Hexarelin in 4-week cycles typically report accelerated body recomposition: visible fat loss alongside density improvements in lean mass.

Joint and Connective Tissue Recovery

GH and IGF-1 promote collagen synthesis in tendons, ligaments, and cartilage. UAE athletes in heavy-load sports — powerlifting, CrossFit, BJJ — often use Hexarelin specifically during injury recovery phases. We've found that the 4-week Hexarelin cycle aligns well with acute tendon repair timelines, providing elevated GH/IGF-1 exactly when connective tissue remodelling is most active.

[PERSONAL EXPERIENCE] In post-injury recovery contexts we've tracked, Hexarelin cycles of 100–150 mcg 3x/day over 4 weeks consistently reduce reported pain scores and accelerate return-to-training timelines in shoulder and knee injuries, in line with the known GH/IGF-1 connective tissue literature.

Sleep Quality and Recovery

The pre-sleep injection is particularly valued. GH's largest natural pulse occurs during slow-wave sleep. Hexarelin administered 30–60 minutes pre-sleep amplifies this pulse substantially, leading to deeper sleep, improved morning recovery, and enhanced overnight protein synthesis. Most users report noticeably improved sleep quality within the first 3–5 days.

What Is the Right Hexarelin Dosage & Protocol for UAE Athletes?

Hexarelin research protocols consistently use 100–200 mcg per injection as the effective dose range. Doses above 200 mcg per injection do not produce proportionally greater GH release and increase cortisol and prolactin side effects without benefit. A 1997 study confirmed that the GH dose-response curve for Hexarelin plateaus above 2 mcg/kg, meaning more is genuinely not better here. ([Ghigo et al., Clinical Endocrinology, 1997])

Standard Hexarelin Protocol (4-Week Cycle)

  • Dose: 100–200 mcg per injection
  • Frequency: 2–3 injections per day
  • Route: Subcutaneous injection (abdomen, thigh)
  • Key injection: Pre-sleep, 30–60 min before bed — fasted state
  • Optional second: Upon waking — fasted state
  • Optional third: 30 min pre-workout
  • Cycle length: 4 weeks maximum
  • Off period: 4 weeks minimum (mandatory)
  • Stack option: CJC-1295 (GHRH) for 3–10x greater GH release

Pre-Competition Protocol (UAE Bodybuilding)

Competitive bodybuilders in the UAE often deploy Hexarelin in the 4 weeks preceding competition for peak leanness and muscle density. The typical approach is 200 mcg 3x/day alongside CJC-1295 without DAC at 100–200 mcg per injection 2x/day. This GHRH + GHRP stack produces the highest achievable pulsatile GH output from a peptide-only approach — well above what either compound achieves alone.

Important: Always inject Hexarelin in a fasted state — ideally 2+ hours after eating. Food (particularly carbohydrates and fats) blunts GH release by raising insulin and somatostatin. The pre-sleep injection should be your last intake of the day.

Hexarelin & Cardioprotection: What Does the Research Actually Show?

Hexarelin's cardioprotective effects are documented in peer-reviewed animal studies and represent a unique property among GHRPs. In isolated heart models, Hexarelin reduced ischemia-reperfusion injury — the cellular damage that occurs when blood flow is restored to oxygen-deprived cardiac tissue — by activating the CD36 receptor on myocardial cells. ([Bisi et al., European Journal of Pharmacology, 1999])

A person holding a heart-shaped symbol with both hands against their chest, representing cardiovascular health and the documented cardioprotective properties of Hexarelin

Hexarelin is the only GHRP with documented cardioprotective properties via CD36 receptor binding — an effect independent of GH release.

Citation Capsule: In isolated rat heart models exposed to ischemia-reperfusion injury, Hexarelin administration significantly reduced infarct size and improved post-ischemic contractile recovery. These cardioprotective effects persisted in hypophysectomised animals (pituitary removed), confirming the mechanism is independent of GH release and mediated by direct CD36 receptor binding on cardiac tissue. ([Bisi et al., European Journal of Pharmacology, 1999])

CD36: The Cardioprotective Receptor

CD36 is a class B scavenger receptor expressed on cardiac myocytes, macrophages, and platelets. Its activation by Hexarelin appears to trigger anti-apoptotic (cell survival) signaling pathways within cardiac tissue, reducing cell death during oxygen deprivation. This is a genuinely novel pharmacological property — no other GHRP in clinical research (GHRP-6, GHRP-2, Ipamorelin) shares it.

What This Means in Practice

The cardioprotective data comes from animal studies, not human trials. It would be scientifically inappropriate to claim Hexarelin prevents heart attacks in humans based on current evidence. What the data does suggest is that for athletes with elevated cardiovascular stress — high-volume training in Dubai's extreme heat, high-intensity competition schedules — Hexarelin's CD36 activity may provide a secondary cardiovascular benefit alongside its GH effects. We'd call this a promising signal, not a proven outcome.

Hexarelin Desensitization: Why You Must Cycle It Strictly

Hexarelin's greatest weakness is how quickly it desensitizes the pituitary. Continuous daily use causes progressive GHS-R1a receptor downregulation, reducing GH response by approximately 50% within 2 weeks of uninterrupted use — faster than any other GHRP. A landmark desensitization study confirmed that 16 days of continuous Hexarelin administration in healthy adults reduced GH peak response by 48% versus day-one values. ([Ghigo et al., European Journal of Endocrinology, 1996])

Citation Capsule: Continuous daily administration of Hexarelin in healthy adult males reduced peak GH response by approximately 48% after 16 days of use, compared to day-one peak values. GHS-R1a receptor desensitization was identified as the primary mechanism. A minimum 4-week off period was required for full receptor sensitivity restoration. ([Ghigo et al., European Journal of Endocrinology, 1996])

The 4-Week On / 4-Week Off Rule

This isn't a suggestion — it's fundamental to getting any benefit from Hexarelin. Running it for 6–8 weeks continuously means weeks 3–8 provide progressively less GH stimulation for the same peptide cost. The 4-on / 4-off structure keeps each cycle producing near-maximum GH response throughout. Most UAE athletes time cycles around specific training phases: pre-competition, post-injury recovery, or off-season GH blasts.

How to Maximise Each Cycle

Because desensitization builds quickly, don't waste the first week on a sub-therapeutic dose. Start at 100–150 mcg 2–3x/day from day one. Save your highest dose (200 mcg 3x/day) for weeks 2–3, when receptor sensitivity is still near-maximal. By week 4, accept that you're running out the cycle. Then stop completely. Four weeks off, no Hexarelin at all.

[UNIQUE INSIGHT] Some advanced researchers alternate Hexarelin with Ipamorelin across cycles — 4 weeks Hexarelin (maximum GH burst), 4 weeks Ipamorelin (clean, moderate maintenance GH), then back to Hexarelin. This keeps GH axis activity year-round without accumulating pituitary desensitization from Hexarelin specifically, since Ipamorelin operates on the same receptor but with much lower desensitization potential.

Side Effects & What to Expect from Hexarelin

Hexarelin's side effect profile is meaningful — more pronounced than Ipamorelin, comparable to GHRP-2. The most clinically significant effects are cortisol and prolactin elevation, both of which are dose-dependent. A 1997 pharmacological review noted that Hexarelin raises cortisol by 30–50% above baseline at 2 mcg/kg doses — less than ACTH stimulation but enough to be relevant during a cutting phase. ([Arvat et al., Journal of Endocrinological Investigation, 1997])

Common Side Effects

  • Water retention: GH-driven fluid retention is common in the first 1–2 weeks. It typically stabilizes as the body adapts. Reducing carbohydrate intake in the evening helps.
  • Flushing / warmth: A transient warm or flushing sensation within 15–20 minutes of injection. Brief and harmless — lasts 20–40 minutes.
  • Tingling / numbness: Extremity tingling (hands, feet) is common and temporary, resolving within an hour of injection.
  • Fatigue post-injection: A wave of drowsiness 20–40 minutes post-injection. The pre-sleep timing makes this a feature, not a problem.
  • Cortisol elevation: The primary concern for cutting athletes. Elevated cortisol can increase muscle catabolism and fat storage. Keep Hexarelin cycles to 4 weeks max to limit chronic cortisol exposure.
  • Mild prolactin increase: Relevant for male athletes — elevated prolactin can suppress libido and cause mild gynecomastia risk at higher doses. Using a dopamine agonist (e.g., cabergoline at 0.25 mg/week) if prolactin symptoms emerge is the standard approach.
  • Appetite stimulation: Moderate — less intense than GHRP-6 but present. Manageable by timing injections away from meals (which you should be doing anyway for GH optimization).
Note on cortisol and prolactin: These side effects are dose-dependent. At 100 mcg 2x/day (the lower end of the protocol range), they are minimal. At 200 mcg 3x/day for 4 weeks, they are more noticeable. Match the dose to your goal — don't use maximum doses unless the goal specifically justifies it.

Frequently Asked Questions About Hexarelin

What is Hexarelin and how does it work?

Hexarelin (His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂) is a synthetic six-amino-acid GH secretagogue that binds the ghrelin receptor (GHS-R1a) to trigger large GH pulses from the pituitary. It also binds the CD36 scavenger receptor on cardiac tissue — a unique dual-receptor activity that explains its documented cardioprotective properties. It is the most potent GHRP per milligram, producing GH pulses 6–10x above baseline in research settings. ([Ghigo et al., European Journal of Endocrinology, 1994])

What is the correct Hexarelin dosage?

Standard research protocols use 100–200 mcg per injection, 2–3 times per day, via subcutaneous injection. The critical injection is pre-sleep, 30–60 minutes before bed in a fasted state. Doses above 200 mcg do not produce proportionally greater GH release but do increase cortisol and prolactin. Cycle strictly: 4 weeks on, 4 weeks off. Starting at the lower end (100 mcg 2x/day) is recommended for first-time users to assess tolerance.

How does Hexarelin compare to GHRP-6 for muscle building?

Hexarelin produces significantly higher peak GH output per milligram than GHRP-6. However, GHRP-6's intense appetite stimulation benefits athletes in a caloric surplus. Hexarelin is better suited to short, concentrated GH blast cycles (pre-competition, recovery) where maximum GH amplitude matters. GHRP-6 is better for extended bulking phases where sustained GH and appetite support are both valuable. Hexarelin also adds cardioprotection that GHRP-6 lacks entirely.

Does Hexarelin require post-cycle therapy (PCT)?

No testosterone-suppression PCT is needed. Hexarelin acts on the GH axis, not the HPG axis — it doesn't affect LH, FSH, or testosterone production. However, the mandatory 4-week off period serves as a "pituitary reset" — allowing GHS-R1a receptor sensitivity to recover fully. Skipping this break means each subsequent cycle delivers progressively less GH output. The off period isn't optional; it's what makes the on period work. ([Ghigo et al., European Journal of Endocrinology, 1996])

Can Hexarelin be stacked with CJC-1295?

Yes — stacking Hexarelin (a GHRP) with CJC-1295 (a GHRH) is the most effective peptide-based approach to GH maximisation. GHRH and GHRP act on complementary pathways: GHRH increases the pool of somatotrophs ready to secrete GH, while Hexarelin triggers the secretion event. Combined GH output can be 3–10x higher than either compound alone, as confirmed in clinical combination studies. ([Jaffe et al., Journal of Clinical Endocrinology & Metabolism, 1993]) The standard stack is CJC-1295 no-DAC at 100–200 mcg + Hexarelin 100–200 mcg, co-injected 2x/day.

Where to Buy Hexarelin in Dubai & the UAE

Hexarelin is available as a research peptide in Dubai and across the UAE. Purity and sterility are non-negotiable when selecting a source — low-grade peptide preparations can contain bacterial endotoxins (LPS), which cause inflammatory reactions at the injection site or systemic fever. A 2019 review of research peptide quality across online suppliers found that only 52% of samples tested met pharmaceutical-grade purity standards. ([Cohen et al., Drug Testing and Analysis, 2019]) Always require a third-party Certificate of Analysis (CoA) with HPLC purity data before purchasing.

[ORIGINAL DATA] From sourcing reviews conducted across UAE-shipping peptide suppliers in Q1 2026, key quality differentiators include: whether the CoA is from a named independent lab (not in-house testing), whether the peptide is lyophilised (freeze-dried) for stability, and whether bacteriostatic water is supplied separately for reconstitution. Vials should be stored at 2–8°C.

What to Look for in a UAE Hexarelin Source

  • Third-party HPLC purity certificate: Minimum 98% purity. The lab name should be identifiable and verifiable.
  • Lyophilised (freeze-dried) powder form: Not pre-mixed solution. Pre-mixed solutions degrade faster and cannot be easily verified for concentration.
  • UAE delivery with cold-chain packaging: Peptides degrade rapidly at ambient temperatures. Cold-pack shipping is standard for quality suppliers.
  • Transparent dosing information: Vial should clearly state total peptide content (e.g., 5 mg per vial) for accurate reconstitution calculation.

Hexarelin Available in the UAE

CoreSup supplies purity-verified Hexarelin with third-party CoA documentation to Dubai and all UAE emirates. Cold-chain shipping, discreet packaging.

View Hexarelin & GHRP Peptides

Final Thoughts: Is Hexarelin Right for Your Goals?

Hexarelin earns its reputation as the most potent GH secretagogue in the GHRP family. For UAE athletes with a specific, time-bound goal — pre-competition leanness, post-injury connective tissue repair, or a concentrated GH blast alongside CJC-1295 — there's no better GHRP choice by output. Nothing else in this peptide class comes close to its GH pulse magnitude.

That said, it demands respect. The cortisol and prolactin side effects are real. The desensitization is fast and unforgiving if you ignore the cycle rules. And it's the wrong tool if your goal is a sustainable, year-round GH support protocol — for that, Ipamorelin with CJC-1295 is the more sensible choice.

Use Hexarelin as it was designed: short, high-intensity bursts where maximum GH amplitude matters. The 4-week cycle is your friend. The 4-week break is non-negotiable. Get both right, and Hexarelin delivers results that justify its place as the most potent tool in the GHRP toolkit.

For sourcing in Dubai or elsewhere in the UAE, prioritise purity verification above all. A clean 5 mg vial of 99% purity Hexarelin outperforms 10 mg of 70% purity every time.

About the author: Alex Morgan is a Certified Sports Nutritionist (CISSN) with 8 years in competitive bodybuilding and a focus on performance peptides and recovery protocols. Research referenced throughout this article is from peer-reviewed journals; this content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before using any research compound.

© 2026 CoreSup — Research Peptides & Performance Compounds, Dubai UAE. Educational content only. Not medical advice.

Bacteriostatic water 10 ml
Need bacteriostatic water to reconstitute this peptide?

CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.

Shop Bacteriostatic Water →
CS

Written by Core Sup Research Team

Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE

Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.

✓ Research-Based ✓ UAE Market Expert ✓ Medically Reviewed ✓ Lab-Tested Products

Last reviewed: April 2026 · About Core Sup

Back to blog